Invention Grant
- Patent Title: Method for prolonging the over survival of a cancer patient
-
Application No.: US15913328Application Date: 2018-03-06
-
Publication No.: US10668093B2Publication Date: 2020-06-02
- Inventor: Jin-Hwang Liu
- Applicant: National Yang-Ming University
- Applicant Address: TW Taipei
- Assignee: National Yang-Ming University
- Current Assignee: National Yang-Ming University
- Current Assignee Address: TW Taipei
- Agency: Marquez IP Law Office, PLLC
- Agent Juan Carlos A. Marquez
- Main IPC: A61K31/704
- IPC: A61K31/704 ; A61K31/167 ; A61K31/20 ; A61K31/502 ; A61K45/06
Abstract:
The present invention relates to a method for treating a cancer with the combination of a topoisomerase II inhibitor (TOP2 inhibitor) and a histone deacetylation inhibitor (HDACi), provides synergistic cancer cell-killing effects, and prolonged overall survival, especially when the expression of checkpoint kinase 1 (CHK-1) is low.
Public/Granted literature
- US20180193367A1 METHOD FOR PROLONGING THE OVER SURVIVAL OF A CANCER PATIENT Public/Granted day:2018-07-12
Information query
IPC分类:
